Colgate-Palmolive (NYSE:CL) Stock Rating Upgraded by TheStreet

Colgate-Palmolive (NYSE:CLGet Rating) was upgraded by TheStreet from a “c+” rating to a “b” rating in a note issued to investors on Friday, TheStreetRatingsTable reports.

A number of other equities research analysts have also issued reports on the company. Deutsche Bank Aktiengesellschaft dropped their price target on Colgate-Palmolive from $91.00 to $88.00 in a research report on Monday. Morgan Stanley increased their price objective on Colgate-Palmolive from $90.00 to $91.00 and gave the stock an “equal weight” rating in a research report on Monday, January 31st. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $78.00 to $76.00 and set an “underweight” rating for the company in a research report on Monday, January 31st. Sanford C. Bernstein upgraded Colgate-Palmolive from an “underperform” rating to a “market perform” rating and increased their price objective for the stock from $77.00 to $83.00 in a research report on Wednesday, February 2nd. Finally, JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $86.00 to $81.00 and set a “neutral” rating for the company in a research report on Wednesday, March 30th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $85.81.

CL stock opened at $75.18 on Friday. The company has a debt-to-equity ratio of 10.45, a current ratio of 1.10 and a quick ratio of 0.67. The business has a 50 day simple moving average of $77.32 and a 200-day simple moving average of $79.07. The firm has a market capitalization of $63.20 billion, a PE ratio of 31.07, a price-to-earnings-growth ratio of 3.79 and a beta of 0.56. Colgate-Palmolive has a 1 year low of $72.20 and a 1 year high of $85.61.

Colgate-Palmolive (NYSE:CLGet Rating) last posted its quarterly earnings results on Friday, April 29th. The company reported $0.74 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.74. The business had revenue of $4.40 billion during the quarter, compared to analyst estimates of $4.40 billion. Colgate-Palmolive had a return on equity of 296.77% and a net margin of 11.70%. The business’s revenue was up 1.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.80 earnings per share. On average, equities research analysts expect that Colgate-Palmolive will post 3.25 EPS for the current year.

Colgate-Palmolive announced that its Board of Directors has initiated a stock repurchase plan on Thursday, March 10th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 8.1% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

In other news, insider Jennifer Daniels sold 40,580 shares of the stock in a transaction on Thursday, February 3rd. The stock was sold at an average price of $82.93, for a total value of $3,365,299.40. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director John P. Bilbrey sold 4,917 shares of the stock in a transaction on Monday, February 14th. The shares were sold at an average price of $78.66, for a total value of $386,771.22. The disclosure for this sale can be found here. Over the last quarter, insiders sold 127,080 shares of company stock worth $10,443,094. Insiders own 0.31% of the company’s stock.

A number of large investors have recently bought and sold shares of the stock. Mattern Capital Management LLC increased its holdings in Colgate-Palmolive by 5.4% in the first quarter. Mattern Capital Management LLC now owns 73,239 shares of the company’s stock valued at $5,554,000 after buying an additional 3,751 shares during the last quarter. Verdence Capital Advisors LLC increased its holdings in Colgate-Palmolive by 21.0% in the first quarter. Verdence Capital Advisors LLC now owns 4,171 shares of the company’s stock valued at $316,000 after buying an additional 725 shares during the last quarter. First Personal Financial Services grew its holdings in shares of Colgate-Palmolive by 4.1% during the first quarter. First Personal Financial Services now owns 86,613 shares of the company’s stock worth $6,568,000 after purchasing an additional 3,434 shares during the last quarter. Valley Brook Capital Group Inc. grew its holdings in shares of Colgate-Palmolive by 2.5% during the first quarter. Valley Brook Capital Group Inc. now owns 8,121 shares of the company’s stock worth $615,000 after purchasing an additional 201 shares during the last quarter. Finally, HNP Capital LLC purchased a new position in shares of Colgate-Palmolive during the first quarter worth about $976,000. 78.12% of the stock is currently owned by hedge funds and other institutional investors.

About Colgate-Palmolive (Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.